New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months Novartis, 12 Oct 2012 Accessed on 16 Oct 2012 from http://www.novartis.com/newsroom/media-releases/en/2012/1648172.shtml. CommentRecommendBookmarkWatch